Publication Topic

Diliberto JJ, Sirinek L, Burkhalter B, Wikoff DS, Hixon G, Becker J, Patterson DG, Turner W, Tachovsky JA, Birnbaum LS, Haws LC. Endometriosis in a cohort of women living in the Kanawha River Valley in West Virginia: Blood levels of non-dioxin-like PCBs and relationship with BMI and age. Presented at Dioxin 2011, Brussels, Belgium, August 2011.

Birnbaum LS, Staskal-Wikoff D. 2010. 5th International PCB Workshop–Summary and implications. Environ Int 36(8):814-818; doi: 10.1016/j.envint.2010.06.011.

Urban JD, Tachovsky JA, Haws LC, Staskal DF, Harris MA. 2010. Response to Buchanan et al.’s comment on Urban et al. “Assessment of Human Health Risks Posed by Consumption of Fish from the Lower Passaic River, New Jersey.” Sci Tot Environ 408(8):2004-2007.

Scott LLF, Staskal DF, Williams ES, Luksemburg WJ, Urban JD, Nguyen LM, Haws LC, Birnbaum LS, Paustenbach DJ, Harris MA. 2009. Levels of polychlorinated dibenzo-p-dioxins, dibenzofurans, and biphenyls in southern Mississippi catfish and estimation of potential health risks. Chemosphere 74(7):1002-10; doi: 10.1016/j.chemosphere.2008.09.090

Harris MA, Shay E, Unice KM, Scott LF, Haws LC. Preliminary evaluation of health risks posed by PCDD/Fs and PCBs from the ingestion of fish from the Lower Passaic River. Presented at Dioxin 2008, Birmingham, England, August 2008.

Scott LLF, Harris MA, Unice KM, Scott P, Nguyen LM, Haws LC, Paustenbach D. 2008. Addendum to: Evaluation of PCDD/F and dioxin-like PCB serum concentration data from the 2001-2002 National Health and Nutrition Examination Survey of the United States population. J Exp Sci Env Epidemiol 18(5):524-532; doi: 10.1038/jes.2008.10.

Ferriby LL, Knutsen JS, Harris MA, Unice KM, Scott P, Nony P, Haws LC, Paustenbach D. 2007. Evaluation of PCDD/F and dioxin-like PCB serum concentration data from the 2001-2002 National Health and Nutrition Examination Survey of the United States Population. J Exp Sci Environ Epidemiol 17(4):358-371; doi: 10.1038/sj.jes.7500498.

Scott LLF, Harris M, Unice KM, Scott P, Nguyen LM, Haws LC, Paustenbach D. 2007. Effects of excluding serum PCDD/F and dioxin-like PCB data of individuals with incomplete congener profiles on estimates of total TEQ. Ann Epidemiol 17(9):732; 10.1016/j.annepidem.2007.07.032.

Scott P, Haws LC, Scott L, Harris M. 2007. Evaluation of background dioxin-like PCB congener profiles in human serum collected during NHANES 2001-2002 using principal components analysis. Dioxin 2007, September 2-7, 2007. Tokyo, Japan.

Ferriby LL, Williams ES, Lukesemburg WJ, Paustenbach DJ, Haws LC, Birnbaum LS, Harris M. Comparing polychlorinated biphenyls in farm-raised and wild-caught catfish from southern Mississippi. Dioxin 2006, Oslo, Norway, August 2006.

Ferriby LL, Williams ES, Lukesemburg WJ, Paustenbach DJ, Haws LC, Birnbaum LS, Harris M. Comparing PCDDs, PCDFs, and dioxin-like PCBs in farm-raised and wild-caught catfish from Southern Mississippi. Dioxin 2006, Oslo, Norway, August 2006.

Ferriby LL, Franke K, Unice KM, Scott P, Haws LC, Harris M, Paustenbach DJ. 2006. Serum reference levels of PCDD/Fs and dioxin-like PCBs stratified by race/ethnicity, gender and age for the general U.S. population. American Public Health Association Annual Meeting and Exposition. November 4-8, 2006. Boston, MA.

Paustenbach DJ, Scott LLF, Nguyen LM, Unice KM, Scott P, Haws LC, Harris M. 2007. Referent concentrations of PCDD/Fs and dioxin-like PCBs in sera of persons in the U.S. Based on the New WHO 2006 TEFs and 2001-2002 NHANES data. Ann Epidemiol 17(9):734.

Haws L. Evaluating potential health risks posed by PCDDs, PCDFs, and dioxin-like PCBs: An approach for improving the Toxicity Equivalency Factor (TEF) methodology. 30th Annual Winter Meeting of the Toxicology Forum, Washington, DC, February 2005.

Haws, L. Roundtable: Is it time to reevaluate the toxic equivalency factors for PCDDs, PCDFs, and dioxin-like PCBs? The use of toxicity equivalence factors (TEFs) for PCDDs, PCDFs, and dioxin-like PCBs in risk assessment: Improving the process. Dioxin 2004. September Berlin, Germany, September 2004.

Haws L, Harris M, Su S, Birnbaum L, DeVito M, Farland W, Walker N, Connor K, Santamaria A, Finley B. Development of a refined database of relative potency estimates to facilitate better characterization of variability and uncertainty in the current mammalian TEFs for PCDDs, PDCFs, and dioxin-like PCBs. Dioxin 2004, Berlin, Germany, 2004.

Warren DA, Kerger BD, Britt JK, James RC. 2004. Development of an oral cancer slope factor for Aroclor 1268. Regul Toxicol Pharmacol 40(1):42-53; doi: 10.1016/j.yrtph.2004.04.005.

Kodavanti PR, Derr-Yellin EC, Mundy WR, Shafer TJ, Herr DW Barone S, Choksi, NY, MacPhail RC, Tilson HA. 1998. Repeated exposure of Aroclor 1254 causes brain region-specific changes in intracellular Ca2+ buffering and protein kinase C activity in the absence of changes in tyrosine hydroxylase. Toxicol Appl Pharmacol 153:186–198; doi: 10.1006/taap.1998.8533.

Finley BL, Burton S, Panko JM, Proctor DM. 1997. A preliminary assessment of PCB risks to human and ecological health in the lower Passaic River. J Soc Environ Tox Chem 52(2):95–118.

Choksi NY, Kodavanti PRS, Tilson H, Booth RG. 1996. Effects of polychlorinated biphenyls on brain tyrosine hydroxylase activity in rats. Fundam Appl Toxicol 39(1):76–80; doi: 10.1006/faat.1997.2351.